Pathstone Family Office’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $1.25M | Buy |
103,177
+289
| +0.3% | +$3.51K | 0.01% | 620 |
|
|
2023
Q2 | $1.29M | Hold |
102,888
| – | – | 0.02% | 408 |
|
|
2023
Q1 | $1.14M | Sell |
102,888
-102,552
| -50% | -$1.14M | 0.02% | 412 |
|
|
2022
Q4 | $2.51M | Buy |
205,440
+1,618
| +0.8% | +$19.8K | 0.02% | 434 |
|
|
2022
Q3 | $2.13M | Buy |
203,822
+101,911
| +100% | +$1.06M | 0.02% | 421 |
|
|
2022
Q2 | $1.09M | Buy |
+101,911
| New | +$1.09M | 0.02% | 322 |
|
|
2020
Q3 | – | Sell |
-4,000
| Closed | -$60K | – | 873 |
|
|
2020
Q2 | $60K | Hold |
4,000
| – | – | 0.01% | 292 |
|
|
2020
Q1 | $37K | Buy |
+4,000
| New | +$37K | 0.01% | 347 |
|